Repositori institucional URV
Español Català English
TÍTOL:
Differences in breast cancer risk after benign breast disease by type of screening diagnosis - imarina:8997881

Autor/s de la URV:SALADIÉ ROIGET, FRANCINA
Autor segons l'article:Louro J; Román M; Posso M; Comerma L; Vidal C; Saladié F; Alcantara R; Sanchez M; Quintana MJ; Del Riego J; Ferrer J; Peñalva L; Bargalló X; Prieto M; Sala M; Castells X
Adreça de correu electrònic de l'autor:francina.saladie@urv.cat
Any de publicació de la revista:2020
Tipus de publicació:Journal Publications
Referència de l'ítem segons les normes APA:Louro J; Román M; Posso M; Comerma L; Vidal C; Saladié F; Alcantara R; Sanchez M; Quintana MJ; Del Riego J; Ferrer J; Peñalva L; Bargalló X; Prieto M; (2020). Differences in breast cancer risk after benign breast disease by type of screening diagnosis. Breast, 54(), 343-348. DOI: 10.1016/j.breast.2020.09.005
Referència a l'article segons font original:Breast. 54 343-348
Resum:© 2020 Introduction: We aimed to assess differences in breast cancer risk across benign breast disease diagnosed at prevalent or incident screens. Materials and methods: We conducted a retrospective cohort study with data from 629,087 women participating in a long-standing population-based breast cancer screening program in Spain. Each benign breast disease was classified as non-proliferative, proliferative without atypia, or proliferative with atypia, and whether it was diagnosed in a prevalent or incident screen. We used partly conditional Cox hazard regression to estimate the adjusted hazard ratios of the risk of breast cancer. Results: Compared with women without benign breast disease, the risk of breast cancer was significantly higher (p-value = 0.005) in women with benign breast disease diagnosed in an incident screen (aHR, 2.67; 95%CI: 2.24–3.19) than in those with benign breast disease diagnosed in a prevalent screen (aHR, 1.87; 95%CI: 1.57–2.24). The highest risk was found in women with a proliferative benign breast disease with atypia (aHR, 4.35; 95%CI: 2.09–9.08, and 3.35; 95%CI: 1.51–7.40 for those diagnosed at incident and prevalent screens, respectively), while the lowest was found in women with non-proliferative benign breast disease (aHR, 2.39; 95%CI: 1.95–2.93, and 1.63; 95%CI: 1.32–2.02 for those diagnosed at incident and prevalent screens, respectively). Conclusion: Our study showed that the risk of breast cancer conferred by a benign breast disease differed according to type of screen (prevalent or incident). To our knowledge, this is the first study to analyse the impact of the screening type on benign breast disease prognosis.
DOI de l'article:10.1016/j.breast.2020.09.005
Enllaç font original:https://www.thebreastonline.com/article/S0960-9776(20)30182-X/fulltext#%20
Versió de l'article dipositat:info:eu-repo/semantics/publishedVersion
Accès a la llicència d'ús:https://creativecommons.org/licenses/by/3.0/es/
Departament:Ciències Mèdiques Bàsiques
URL Document de llicència:https://repositori.urv.cat/ca/proteccio-de-dades/
Àrees temàtiques:Surgery
Sociología
Saúde coletiva
Oncology
Odontología
Obstetrics & gynecology
Medicine (miscellaneous)
Medicina iii
Medicina ii
Medicina i
General medicine
Educação física
Ciências biológicas ii
Ciências biológicas i
Cancer research
Biotecnología
Paraules clau:Risk factors
Early cancer detection
Breast neoplasms
Benign breast disease
Entitat:Universitat Rovira i Virgili
Data d'alta del registre:2022-07-10
Cerca el teu registre a:

Fitxers disponibles
FitxerDescripcióFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Informació

© 2011 Universitat Rovira i Virgili